Pharmaceutical compositions and method of treating Parkinson's disease

Details for Australian Patent Application No. 2003301109 (hide)

International Classifications

Event Publications

27 May 2004 Complete Application Filed

Priority application(s): 60/448,833 20.02.03 US; 60/436,051 23.12.02 US

26 August 2004 Application Open to Public Inspection

Published as AU-B-2003301109

25 August 2005 Corrigenda

Applications OPI - Name Index Under the name MERCK FROSST CANADA AND CO., Application No. 2003301109, under INID (71) correct the name to read Merck Frosst Canada & Co; University of Medicine and Dentistry of New Jersey.

16 March 2006 Assignment before Grant

Merck Frosst Canada & Co; University of Medicine and Dentistry of New Jersey The application has been assigned to University of Medicine and Dentistry of New Jersey; Merck Frosst Company

25 June 2009 Application Accepted

Published as AU-B-2003301109

22 October 2009 Standard Patent Sealed

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.